Colivelin, a fusion of ADNF9 and a Humanin analog, had neuroprotective activity in the fM range, about 10(3)-10(7) fold higher than Humanin and Humanin analogs.
In plain wordsIn lab tests, a Humanin-based fusion peptide protected nerve cells at far lower concentrations than Humanin and Humanin analogs.
- Peptide
- Humanin
- Outcome
- IncreaseNeuroprotective activity of Colivelin versus Humanin
- Study
n: not reported in source
- Comparator
- Humanin and Humanin analogs
- Outcome group
- Neuroprotection · Nervous system and cognition
Source sentences
This fusion resulted in a novel molecule, termed Colivelin, with the neuroprotective activity at fM range, which is approximately 10(3)-10(7) fold higher than the activity of Humanin and Humanin analogs and follows the activity profile of fM-active ADNF9.
In this study, Humanin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Humanin.